Kate Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Kate Therapeutics, or KateTx, is a biotechnology company focused on developing gene therapies that use adeno-associated virus vectors to treat inherited muscle and heart diseases. The firm aims to address key limitations of current gene therapies by pursuing tissue-specific delivery and regulated gene activity to improve safety and efficacy. Based in San Diego, California, KateTx operates with a relatively small to mid-sized team. Its work centers on advancing genetic medicines that can target conditions that are difficult to address with existing approaches.

The company serves researchers and biopharmaceutical partners pursuing next-generation gene therapies for muscle and related neuromuscular conditions, offering collaboration to accelerate development. A recent development noted in industry coverage is a collaboration with RatioTx, reflecting ongoing partnership activity as part of KateTx's development efforts.

Sign up for free to view info

Company overview Employee directory